Navigation Links
Substance protects resilient staph bacteria

Researchers have identified a promising new target in their fight against a dangerous bacterium that sickens people in hospitals, especially people who receive medical implants such as catheters, artificial joints and heart valves.

A substance found on the surface of Staphylococcus epidermidis has, for the first time, been shown to protect the harmful pathogen from natural human defense mechanisms that would otherwise kill the bacteria, according to scientists at the Rocky Mountain Laboratories (RML), part of the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health.

S. epidermidis is one of several hard-to-treat infectious agents that can be transmitted to patients in hospitals via contaminated medical implants. The new report concludes that the substance--known as poly-gamma-DL-glutamic acid, or PGA--must be present for S. epidermidis to survive on medical implants. S. epidermidis infections are rarely fatal but can lead to serious conditions such as sepsis (widespread toxic infection) and endocarditis (inflammation of the lining of the heart and its valves).

Because of the ability of PGA to promote resistance to innate immune defenses, learning more about the protein could lead to new treatments for S. epidermidis and related Staphylococcal pathogens that also produce PGA, according to the RML scientists. In addition, they also are hoping that similar research under way elsewhere on Bacillus anthracis--the infectious agent of anthrax, which also produces PGA--will complement their work.

The report of the study, led by Michael Otto, Ph.D., will appear in the March edition of The Journal of Clinical Investigation and is now available online. Collaborators, all scientists at RML in Hamilton, MT, include Stanislava Kocianova, Ph.D.; Cuong Vuong, Ph.D.; Yufeng Yao, Ph.D.; Jovanka Voyich, Ph.D.; Elizabeth Fischer, M.A.; and Frank DeLeo, Ph.D.

"Nosocomial, or hospital-acquired, infection
'"/>

Source:NIH/National Institute of Allergy and Infectious Diseases


Page: 1 2

Related biology news :

1. Bound for destruction: Ubiquitination protects against improper Notch signaling
2. Experiments provide proof of how traveling in groups protects insects
3. Experiments provide proof of how traveling in groups protects insects
4. Molecule that usually protects infection-fighting cells may cause plaque deposits inside arteries
5. NSAID drug protects against intestinal tumors in mice, despite poor diet and gene losses
6. Mutation in clams protects against paralytic shellfish poisoning but raises human health risk
7. Excess liver gene protects against high-fat diet
8. New vaccine protects more effectively against tuberculosis
9. New type of rejection blocker protects kidneys after transplant
10. How cell suicide protects plants from infection
11. Envisat radar surveillance protects endangered prehistoric fish

Post Your Comments:
(Date:11/23/2009)...urrent research suggests that a common oral bacter...d report by Nichols et al, "Unique Lipids from a C...2 Ligands Capable of Enhancing Autoimmunity," appe...urnal of Pathology . , Multiple sclerosis (MS), ...n and spinal cord, affects nearly 1 in 700 people ...
(Date:11/23/2009)... - By producing some of the highest resolution ima...entists have a deeper understanding how biomolecul...ay lead to a new treatment for kidney stones using...the Nov. 23 online edition of the journal Proceed...s how peptides interact with mineral surfaces by a...
(Date:11/23/2009)...niversity of New Hampshire microbiologist Louis Ti...vance understanding of the actinorhizal plants, wi...rient-poor and contaminated soils. , The United...isa, a professor of molecular, cellular and biomed...elationship between the bacteria Frankia and Casua...
Breaking Biology News(10 mins):Factors from common human bacteria may trigger multiple sclerosis 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3UNH prof. receives nearly $500,000 to research environmentally significant plants 2Psoriasis Video Contest Launched to Encourage Psoriasis Patients to Connect and Collaborate 54344 1Psoriasis Video Contest Launched to Encourage Psoriasis Patients to Connect and Collaborate 54344 2Scientists Reverse Multiple Sclerosis in Mice 54342 1Scientists Reverse Multiple Sclerosis in Mice 54342 2Human mind 3A Sound and vision wired through same black box 54340 1Human mind 3A Sound and vision wired through same black box 54340 2
... A team led by Duke University Medical Center rese...uds on the surface of the tongue that are responsi...fic basis of other primary types of flavors, such ...tudy to define how humans perceive sour taste, sai...an assistant professor of molecular genetics and m...
... The U.S. Agriculture Department,s mad cow disease...cy,s refusal to let processors do their own testin... University of Illinois scholar writes. , Eating m...cephalopathy, or mad cow disease, can cause Creutz...isorder. More than 160 deaths in Britain were attr...
... See the picture in the original press release ,...e jungle has captured the first-ever photo of a rh...dlife Fund and the Sabah Wildlife Department annou... population of as few as 13 whose existence was co...erior forests of Sabah, Malaysia, an area known as...
Other Biology News:Scientists solve sour taste proteins 2Scientists solve sour taste proteins 3Federal testing for mad cow disease a failure, law review editor says 2Federal testing for mad cow disease a failure, law review editor says 3Federal testing for mad cow disease a failure, law review editor says 4WWF captures first-ever photo of wild rhino on Borneo 2
(Date:11/24/2009)... Health care employment gre... the only one to show consistent growth during the...spitals remain in trouble, and health systems are ...rsonnel, instead of just administrators. , ...lth care employment continued growing in October d...
(Date:11/24/2009)..., SANMATEO,Calif.,Nov.24/PRNewswire-FirstCall/--...mpanyfocusedondevelopingandcommercializingnovelpai...nno,PresidentandChiefExecutiveOfficer,isscheduledt...rence,tobeheldDecember1-2,2009atTheNewYorkPalaceHo...iglieri,ChiefFinancialOfficer,willbeavailabletores...
(Date:11/24/2009)... The FBI recently approved th...tories participating in or generating DNA records ... Madison, WI USA (PRWEB) -- The FBI rec...ystem for use by laboratories participating in, o...ex System (NDIS). NDIS currently contains more tha...
(Date:11/24/2009)..., DUBLIN,November24/PRNewswire-FirstCall/--Shire...pharmaceuticalcompany,today,announcedthatithassubm...rasealfa,thecompany,senzymereplacementtherapyindev...isthethirdmarketing,applicationforvelaglucerasealf...eUnitedStatesandCanada. , Basedonaglobalsuppl...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3
..., Calif., May 28 CV Therapeutics,Inc. (Nasdaq: C...daq,marketplace rule 4350, the Company issued new ...ers due to additional hiring, primarily in connect...ed States., The inducement stock options cover an...classified as non-qualified stock options with an,...
...Genmab Reports Results for the First Three Months ...N),announced today results for the three month per...ab reported the following results:, Genmab,s reve... for the,first quarter of 2008. In the same period...lion (approx. USD 17 million)., An operating loss...
...hio, May 28 The automation of,transaction-based p...alth,plans in the United States. Foresight Corpora...mber and scale of installations of Transaction,Ins...n automation., Transaction automation techniques ... costs significantly by integrating validation, er...
Other Biology Technology:CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350 2Genmab Announces 2008 First Quarter Results 2Genmab Announces 2008 First Quarter Results 3Genmab Announces 2008 First Quarter Results 4New Trend Sweeping Nation's Health Plans: Transaction Automation 2
Vybrant Apoptosis Assay Kit #7 - Hoechst 33342/YO-PRO-1/propidium iodide - 200 assays from Molecular Probes (Invitrogen)
Rat TIMP-1 ELISA Kit from R&D Systems
Human Embryonic Stem Cell Marker Antibody Panel. Contains 25 g each of anti-Alkaline Phosphatase, anti-Nanog, anti-Oct-3/4, anti-SSEA-1, and anti-SSEA-4. from R&D Systems
HSV 1 IgG ELISA Kit from Biomeda Corporation
Biology Products: